Agilent Technologies Long-Term Investments 2010-2025 | A

Agilent Technologies long-term investments from 2010 to 2025. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Agilent Technologies long-term investments for the quarter ending April 30, 2025 were $173M, a 1.76% increase year-over-year.
  • Agilent Technologies long-term investments for 2024 were $0.175B, a 6.71% increase from 2023.
  • Agilent Technologies long-term investments for 2023 were $0.164B, a 15.9% decline from 2022.
  • Agilent Technologies long-term investments for 2022 were $0.195B, a 5.41% increase from 2021.
Agilent Technologies Annual Long-Term Investments
(Millions of US $)
2024 $175
2023 $164
2022 $195
2021 $185
2020 $158
2019 $102
2018 $68
2017 $138
2016 $135
2015 $86
2014 $96
2013 $139
2012 $109
2011 $117
2010 $142
2009 $163
Agilent Technologies Quarterly Long-Term Investments
(Millions of US $)
2025-01-31 $173
2024-10-31 $175
2024-07-31 $186
2024-04-30 $177
2024-01-31 $170
2023-10-31 $164
2023-07-31 $190
2023-04-30 $186
2023-01-31 $188
2022-10-31 $195
2022-07-31 $194
2022-04-30 $190
2022-01-31 $191
2021-10-31 $185
2021-07-31 $204
2021-04-30 $188
2021-01-31 $165
2020-10-31 $158
2020-07-31 $148
2020-04-30 $141
2020-01-31 $118
2019-10-31 $102
2019-07-31 $99
2019-04-30 $96
2019-01-31 $77
2018-10-31 $68
2018-07-31 $70
2018-04-30 $139
2018-01-31 $140
2017-10-31 $138
2017-07-31 $137
2017-04-30 $134
2017-01-31 $133
2016-10-31 $135
2016-07-31 $155
2016-04-30 $157
2016-01-31 $76
2015-10-31 $86
2015-07-31 $88
2015-04-30 $91
2015-01-31 $90
2014-10-31 $96
2014-07-31 $164
2014-04-30 $133
2014-01-31 $129
2013-10-31 $139
2013-07-31 $124
2013-04-30 $120
2013-01-31 $128
2012-10-31 $109
2012-07-31 $104
2012-04-30 $111
2012-01-31 $110
2011-10-31 $117
2011-07-31 $122
2011-04-30 $123
2011-01-31 $134
2010-10-31 $142
2010-07-31 $136
2010-04-30 $158
2010-01-31 $154
2009-10-31 $163
2009-07-31 $153
2009-04-30 $167
2009-01-31 $169
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $33.778B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $237.401B 28.55
Boston Scientific (BSX) United States $145.814B 36.50
Stryker (SYK) United States $145.229B 30.37
EssilorLuxottica (ESLOY) France $130.605B 0.00
Medtronic (MDT) Ireland $113.492B 16.09
Lonza Group Ag (LZAGY) Switzerland $51.916B 0.00
Haleon (HLN) United Kingdom $49.556B 28.23
ResMed (RMD) United States $36.981B 27.78
GE HealthCare Technologies (GEHC) United States $33.476B 15.89
Terumo (TRUMY) Japan $27.213B 35.35
Koninklijke Philips (PHG) Netherlands $22.201B 15.96
Insulet (PODD) United States $21.367B 83.87
Zimmer Biomet Holdings (ZBH) United States $18.451B 11.85
Baxter (BAX) United States $16.093B 12.02
Smith & Nephew SNATS (SNN) United Kingdom $13.187B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.325B 22.01
Lantheus Holdings (LNTH) United States $5.545B 13.99
Prestige Consumer Healthcare (PBH) United States $4.207B 18.80
Perrigo (PRGO) Ireland $3.746B 9.49
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.428B 15.61
ICU Medical (ICUI) United States $3.258B 24.02
Envista Holdings (NVST) United States $3.198B 26.58
GN Store Nord (GNNDY) Denmark $2.319B 19.20
QuidelOrtho (QDEL) United States $2.021B 13.90
LeMaitre Vascular (LMAT) United States $1.839B 41.10
AtriCure (ATRC) United States $1.600B 0.00
Acuren (TIC) United States $1.308B 0.00
Neogen (NEOG) United States $1.220B 15.61
AdaptHealth (AHCO) United States $1.187B 12.05
BioLife Solutions (BLFS) United States $1.107B 0.00
Green Thumb Industries (GTBIF) United States $1.061B 23.86
Phibro Animal Health (PAHC) United States $0.993B 12.70
Kestra Medical Technologies (KMTS) United States $0.963B 0.00
InMode (INMD) Israel $0.888B 8.95
CeriBell (CBLL) United States $0.657B 0.00
Evolus (EOLS) United States $0.656B 0.00
Capricor Therapeutics (CAPR) United States $0.637B 0.00
Owens & Minor (OMI) United States $0.616B 5.11
Maravai LifeSciences Holdings (MRVI) United States $0.576B 0.00
Curaleaf Holdings (CURLF) Canada $0.547B 0.00
Valneva SE (VALN) France $0.523B 0.00
Tilray Brands (TLRY) Canada $0.419B 0.00
Surmodics (SRDX) United States $0.416B 0.00
SNDL (SNDL) Canada $0.355B 0.00
VAREX IMAGING (VREX) United States $0.351B 12.92
Aurora Cannabis (ACB) Canada $0.342B 60.90
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Canopy Growth (CGC) Canada $0.281B 0.00
Viemed Healthcare (VMD) United States $0.268B 22.60
Sanuwave Health (SNWV) United States $0.265B 0.00
Cerus (CERS) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.258B 11.75
Sanara MedTech (SMTI) United States $0.255B 0.00
Cresco Labs (CRLBF) United States $0.251B 0.00
Quanterix (QTRX) United States $0.240B 0.00
OraSure Technologies (OSUR) United States $0.219B 0.00
Biote (BTMD) United States $0.216B 6.08
Brainsway (BWAY) Israel $0.216B 57.10
TriSalus Life Sciences (TLSI) United States $0.208B 0.00
Omeros (OMER) United States $0.208B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.189B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.18
Verano Holdings (VRNOF) United States $0.180B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.143B 0.00
FitLife Brands (FTLF) United States $0.134B 16.51
Jin Medical (ZJYL) China $0.109B 0.00
MacroGenics (MGNX) United States $0.098B 0.00
Veru (VERU) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Fonar (FONR) United States $0.090B 11.60
Quipt Home Medical (QIPT) United States $0.089B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.067B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Zynex (ZYXI) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.043B 0.00
Nephros (NEPH) United States $0.043B 57.29
United-Guardian (UG) United States $0.038B 13.02
Rockwell Medical (RMTI) United States $0.033B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
INLIF (INLF) $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00